Skip to main content
Top

International Journal of Clinical Oncology

Issue 2/2014

Content (28 Articles)

Introduction to Review Articles

Multidisciplinary approach for the treatment of head and neck cancer

Masato Fujii

Original Article

A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer

Jiayi Huang, Andrew M. Baschnagel, Peter Chen, Gregory Gustafson, Ishmael Jaiyesmi, Mitchell Folbe, Hong Ye, Jan Akervall, Daniel Krauss

Original Article

Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil

Sung Hak Lee, Eun Ji Choi, Min Sik Kim, Jun Wook Park, Youn Soo Lee, Su Young Kim, Chang Suk Kang

Original Article

CD133 expression: a potential prognostic marker for non-small cell lung cancers

Hidenori Mizugaki, Jun Sakakibara-Konishi, Junko Kikuchi, Jun Moriya, Kanako C. Hatanaka, Eiki Kikuchi, Ichiro Kinoshita, Satoshi Oizumi, Hirotoshi Dosaka-Akita, Yoshihiro Matsuno, Masaharu Nishimura

Original Article

Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis

Naohiro Watanabe, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Osamu Nishiyama, Masashi Kondo, Yoshinori Hasegawa

Original Article

Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer

Taichiro Goto, Arafumi Maeshima, Yoshitaka Oyamada, Ryoichi Kato

Original Article

Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer

Yasuhiro Suzuki, Rin Ogiya, Risa Oshitanai, Mayako Terao, Mizuho Terada, Toru Morioka, Banri Tsuda, Naoki Niikura, Takuho Okamura, Yuki Saito, Yutaka Tokuda

Original Article

Clinicopathologic characteristics and survival of male breast cancer

Dongying Liu, Guangru Xie, Ming Chen

Original Article

Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients

Thomas Thomaidis, Arndt Weinmann, Martin Sprinzl, Stephan Kanzler, Jochen Raedle, Matthias Ebert, Carl Cristoph Schimanski, Peter Robert Galle, Thomas Hoehler, Markus Moehler

Original Article

Safety and efficacy of nimotuzumab in combination with radiotherapy for patients with squamous cell carcinoma of the esophagus

Ning-Yi Ma, Xu-Wei Cai, Xiao-Long Fu, Yuan Li, Xiao-Yan Zhou, Xiang-Hua Wu, Xi-Chun Hu, Min Fan, Jia-Qing Xiang, Ya-Wei Zhang, Hai-Quan Chen, Song-Tao Lai, Guo-Liang Jiang, Kuai-Le Zhao

Original Article

Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer

Yiting Geng, Xiaofeng Chen, Jinrong Qiu, Yue Zhou, Jian Wang, Lingxiang Liu, Yongfeng Shao, Yongmei Yin

Original Article

Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results

Masahiro Morimoto, Fumiaki Isohashi, Yasuo Yoshioka, Osamu Suzuki, Yuji Seo, Toshiyuki Ogata, Yuichi Akino, Masahiko Koizumi, Kazuhiko Ogawa

Original Article

A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder

Zhulin Yang, Zhi Yang, Qiong Zou, Yuan Yuan, Jinghe Li, Daiqiang Li, Lufeng Liang, Guixiang Zeng, Senlin Chen

Original Article

A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix

Eriko Takatori, Tadahiro Shoji, Yasuko Suga, Hanae Niinuma, Yuki Miura, Yoshitaka Kaido, Anna Takada, Masahiro Kagabu, Satoshi Takeuchi, Toru Sugiyama

Original Article

Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2–IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review

Shiho Kuji, Yasuyuki Hirashima, Satomi Komeda, Aki Tanaka, Masakazu Abe, Nobutaka Takahashi, Munetaka Takekuma, Hirofumi Asakura, Hideyuki Harada, Tetsuo Nishimura

Original Article

Outcome of stage IB2–IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy

Kazunori Uegaki, Muneaki Shimada, Seiya Sato, Imari Deura, Jun Naniwa, Shinya Sato, Tetsuro Oishi, Hiroaki Itamochi, Tasuku Harada, Junzo Kigawa

Original Article

Curcumin targets the AKT–mTOR pathway for uterine leiomyosarcoma tumor growth suppression

Tze Fang Wong, Takashi Takeda, Bin Li, Kenji Tsuiji, Akiko Kondo, Mari Tadakawa, Satoru Nagase, Nobuo Yaegashi

Original Article

Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker

Yutaka Ihata, Etsuko Miyagi, Reiko Numazaki, Takahiko Muramatsu, Akira Imaizumi, Hiroshi Yamamoto, Minoru Yamakado, Naoyuki Okamoto, Fumiki Hirahara

Original Article

Pathological outcomes of Japanese men eligible for active surveillance after radical prostatectomy

Takahiro Inoue, Hidefumi Kinoshita, Hidekazu Inui, Yoshihiro Komai, Masayuki Nakagawa, Naoki Oguchi, Gen Kawa, Motohiko Sugi, Chisato Ohe, Chika Miyasaka, Yorika Nakano, Noriko Sakaida, Yoshiko Uemura, Tadashi Matsuda

Original Article

Multiple primary malignancies in elderly patients with high-grade soft tissue sarcoma

Eiji Kozawa, Hideshi Sugiura, Satoshi Tsukushi, Hiroshi Urakawa, Eisuke Arai, Naohisa Futamura, Hiroatsu Nakashima, Yoshihisa Yamada, Naoki Ishiguro, Yoshihiro Nishida

Original Article

Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia

Takashi Shibata, Yosuke Minami, Ayako Mitsuma, Sachi Morita, Megumi Inada-Inoue, Tomoyo Oguri, Tomoya Shimokata, Mihoko Sugishita, Tomoki Naoe, Yuichi Ando

Original Article

Usefulness of one-point plasma SN-38G/SN-38 concentration ratios as a substitute for UGT1A1 genetic information after irinotecan administration

Kouichi Hirose, Koushiro Yamashita, Hirofumi Takada, Noriko Kaneda, Kohei Fukami, Eiji Maruo, Mizuho Kitamura, Junichi Hasegawa, Yorinobu Maeda

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine